Siren Bio

Siren Biotechnology

The company develops adeno-associated virus immuno-gene therapies to treat solid tumour cancers for healthcare providers and patients.

KiraGen Bio

This biotechnology company develops gene-edited cell therapies to treat solid tumours for patients with glioblastoma and other cancers.

Stratosvir

This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.

OverT Bio

This company develops engineered cell therapies and genetic screening platforms to treat patients with solid tumour cancers.

Kindling Bio

This company develops a gene therapy platform that engineers tumour cells to display markers for the immune system to treat children with solid tumours.

Vivere Oncotherapies

This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.

Sift Bio

The company develops a peptide immunotherapy platform that uses artificial intelligence to identify microbial analogs for treating solid tumours in cancer patients.

Abalos Therapeutics

This company develops arenavirus-based immuno-virotherapies to treat solid tumours and metastases for patients with cancer.